Authors:
Segman, RH
Heresco-Levy, U
Finkel, B
Goltser, T
Shalem, R
Schlafman, M
Dorevitch, A
Yakir, A
Greenberg, D
Lerner, A
Lerer, B
Citation: Rh. Segman et al., Association between the serotonin 2A receptor gene and tardive dyskinesia in chronic schizophrenia, MOL PSYCHI, 6(2), 2001, pp. 225-229
Authors:
Segman, RH
Heresco-Levy, U
Finkel, B
Inbar, R
Neeman, T
Schlafman, M
Dorevitch, A
Yakir, A
Lerner, A
Goltser, T
Shelevoy, A
Lerer, B
Citation: Rh. Segman et al., Association between the serotonin 2C receptor gene and tardive dyskinesia in chronic schizophrenia: additive contribution of 5-HT2C(ser) and DRD3(gly) alleles to susceptibility, PSYCHOPHAR, 152(4), 2000, pp. 408-413
Citation: U. Heresco-levy, N-methyl-D-aspartate (NMDA) receptor-based treatment approaches in schizophrenia: the first decade, IN J NEUROP, 3(3), 2000, pp. 243-258
Authors:
Segman, R
Neeman, T
Heresco-Levy, U
Finkel, B
Karagichev, L
Schlafman, M
Dorevitch, A
Yakir, A
Lerner, A
Shelevoy, A
Lerer, B
Citation: R. Segman et al., Genotypic association between the dopamine D3 receptor and tardive dyskinesia in chronic schizophrenia, MOL PSYCHI, 4(3), 1999, pp. 247-253
Authors:
Agid, O
Shapira, B
Zislin, J
Ritsner, M
Ritsner, M
Hanin, B
Murad, H
Troudart, T
Bloch, M
Heresco-Levy, U
Lerer, B
Citation: O. Agid et al., Environment and vulnerability to major psychiatric illness: a case controlstudy of early parental loss in major depression, bipolar disorder and schizophrenia, MOL PSYCHI, 4(2), 1999, pp. 163-172
Citation: T. Levin et U. Heresco-levy, Risperidone-induced rabbit syndrome: an unusual movement disorder caused by an atypical antipsychotic, EUR NEUROPS, 9(1-2), 1999, pp. 137-139
Authors:
Heresco-Levy, U
Javitt, DC
Ermilov, M
Mordel, C
Silipo, G
Lichtenstein, M
Citation: U. Heresco-levy et al., Efficacy of high-dose glycine in the treatment of enduring negative symptoms of schizophrenia, ARCH G PSYC, 56(1), 1999, pp. 29-36